---
figid: PMC7855613__nihms-1643444-f0004
figtitle: Glycosylation in oncogenic signaling pathways
organisms:
- Phaseolus vulgaris
- Sambucus nigra
- Maackia amurensis
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Bos taurus
- Betapolyomavirus macacae
- Campylobacter jejuni
- Patella vulgata
pmcid: PMC7855613
filename: nihms-1643444-f0004.jpg
figlink: /pmc/articles/PMC7855613/figure/F4/
number: F4
caption: Aberrant glycosylation of cell surface receptors, growth factors, and transmembrane
  proteins activates various intracellular signaling pathways such as Wnt/β-catenin,
  Notch, TGFβ/Smad, PI3K/Akt, Integrin-mediated FAK signaling in tumor cells. Aberrant
  glycosylation of Wnt ligand promotes nuclear translocation of β-catenin and enhance
  cell-cell adhesion and metastasis. The presence of modified N-glycans on TGF-β ligand
  modulates cell-matrix interaction and promote EMT. Altered glycosylation of Notch
  ligand promotes cancer cell survival and stem cell proliferation. Aberrant glycosylation
  of integrins activates FAK signaling pathway and promotes ECM remodeling. Altered
  glycosylation of EGF receptors promotes genomic stability and cancer stemness.
papertitle: 'Altered glycosylation in cancer: A promising target for biomarkers and
  therapeutics.'
reftext: Divya Thomas, et al. Biochim Biophys Acta Rev Cancer. ;1875(1):188464-188464.
year: '2021'
doi: 10.1016/j.bbcan.2020.188464
journal_title: Biochimica et biophysica acta. Reviews on cancer
journal_nlm_ta: Biochim Biophys Acta Rev Cancer
publisher_name: ''
keywords: Cancer | glycans | glycosyltransferases | biomarker | vaccines | glycoconjugate
  drugs
automl_pathway: 0.8807714
figid_alias: PMC7855613__F4
figtype: Figure
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Mus musculus
- Bos taurus
redirect_from: /figures/PMC7855613__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7855613__nihms-1643444-f0004.html
  '@type': Dataset
  description: Aberrant glycosylation of cell surface receptors, growth factors, and
    transmembrane proteins activates various intracellular signaling pathways such
    as Wnt/β-catenin, Notch, TGFβ/Smad, PI3K/Akt, Integrin-mediated FAK signaling
    in tumor cells. Aberrant glycosylation of Wnt ligand promotes nuclear translocation
    of β-catenin and enhance cell-cell adhesion and metastasis. The presence of modified
    N-glycans on TGF-β ligand modulates cell-matrix interaction and promote EMT. Altered
    glycosylation of Notch ligand promotes cancer cell survival and stem cell proliferation.
    Aberrant glycosylation of integrins activates FAK signaling pathway and promotes
    ECM remodeling. Altered glycosylation of EGF receptors promotes genomic stability
    and cancer stemness.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MUC5AC
  - EGF
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - GSK3B
  - AXIN1
  - AXIN2
  - APC
  - PROC
  - CTNNB1
  - SMAD4
  - SMAD1
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - PTK2
  - TGFB1
  - TGFB2
  - TGFB3
  - ITGA1
  - ITGA10
  - ITGA11
  - ITGA2
  - ITGA2B
  - ITGA3
  - ITGA4
  - ITGA5
  - ITGA6
  - ITGA7
  - ITGA8
  - ITGA9
  - ITGAD
  - ITGAE
  - ITGAL
  - ITGAM
  - ITGAV
  - ITGAX
  - ITGB1
  - ITGB2
  - ITGB3
  - ITGB4
  - ITGB5
  - ITGB6
  - ITGB7
  - ITGB8
  - ITGBL1
  - ITK
  - SLC22A3
  - Slc13a2
  - Egf
  - Notch1
  - Wnt2
  - Gsk3b
  - Axin1
  - Apc
  - Ctnnb1
  - Smad4
  - Ptk2
  - Tgfb1
  - Slc22a3
  - Ltbp1
  - Itk
  - MUC1
  - DMBT1
---
